. (1985). Toxicol. Appl. Pharmacol. 81,545-550. The present study was undertaken to compare the effectiveness of a new water-soluble benzodiazepine, midazolam, to diazepam, both administered im for protection against diethyl-pnitrophenyl phosphate (paraoxon) toxicity. Adult male Sprague-Dawley rats were pretreated with midazolam or diazepam (0.32-32.0 mgkg) alone or in combination with atropine (10.0 mg/kg). Twenty minutes later 2~ LD50 of paraoxon was injected sc and the incidence of seizures and death were recorded for 24 hr. In another series of experiments, the LD50 of paraoxon was evaluated in the rats pretreated im with atropine (10.0 mgkg) and midaxolam or diazepam (10.0 mg/kg). Pretreatment with atropine alone did not prevent paraoxon-induced seizures but did reduce mortality. Both benzodiazepines were very effective alone or when combined with atropine in reducing the incidence of paraoxon-induced seizures. When given alone, neither benzodiazepine protected against paraoxon-induced mortality. However, when combined with atropine both benzodiazepines dramatically decreased the lethality of 2X LD50 of paraoxon. In equal doses given im, midazolam proved to be more potent than diazepam. Q
It is generally accepted that inhibition of acetylcholinesterase (AChE) results in an accumulation of acetylcholine (ACh) which may be responsible for the acute toxic effects of organophosphorous (OP) compounds. Although atropine has long been used in the treatment of poisoning by acetylcholinesterase inhibitors (AChEI), including OP agents, it does not significantly reduce convulsions nor does it drastically alter their LD50 values. Inasmuch as antimuscarinic and ganglionic blocking agents alone or together do not provide sufficient antidotal activity against OP AChEIs, it follows that ACh may not be the only transmitter involved in their CNS actions. OP-induced convulsions may be related to reduced effectiveness of y-aminobutyric acid (GABA) in the ' A preliminary report was presented at the FiBh Annual Chemical Defense Bioscience Review sponsored by the U.S. Army Medical Research Insitute of Chemical Defense, Columbia, Md. and at the International Meeting "Neurobiology of Acetylcholine," Loyola University, Chicago, Ill.
2 Supported in part by the Psychopharmacology Research Fund (Domino) and the U.S. Army Medical Research and Development Command brain (Kar and Matin, 1972; Matin and Kar, 1973; Lundy et al., 1978) . Further studies on the detailed mechanisms involving GABA still need to be done.
Recent in vitro and in vivo studies (Haefely et al., 198 1; Meldrum and Braestrup, 1983) have shown that benzodiazepines enhance the postsynaptic inhibitory actions of GABA (both exogenous and synaptically released). Indeed, benzodiazepines are the most potent of the clinically available anticonvulsants, particulary when seizures are chemically induced by a large variety of substances. At least five reports have suggested that diazepam is potentially useful as an antidote against poisoning by AChEI (Lipp, 1972 (Lipp, , 1973 Rump et al., 1973; Johnson and Lowndes, 1974; Johnson and Wilcox, 1975) . However, significant disadvantages are associated with the im administration of diazepam. The im use of this compound has almost disappeared from clinical practice (Reves et al., 1984) because the drug is poorly absorbed, the injection is painful, and there is considerable local irritation. Therefore, evaluation of the anticonvulsant activity of novel, water soluble benzodiazepines such as midazolam is necessary. In general, midazo-545 0041-008X/85 $3.00 copyright 8 198s by Academic Press, Inc. Au right.9 of reproduction i n any form -ed.
lam, which shares the common pharmacodynamic properties and mechanisms of action with all benzodiazepines, has a shorter duration of action than does diazepam but is more potent. With regard to central nervous system GABA receptor binding, midazolam has a fivefold greater affinity than does diazepam (Mohler and Okada, 1977) . Midazolam appears to be an ideal compound for im injection. After adminstration of the water-soluble preparation, the midazolam ring closes, causing the drug to become highly lipid soluble and to rapidly cross the blood brain barrier. The present study was initiated to determine if midazolam had any advantages over diazepam in the treatment of paraoxon toxicity in an animal model.
METHODS
A total of 550 adult male Sprague-Dawley (Harlan Inc., Indianapolis, Ind.) rats, 250 to 404 g, were used in these experiments. They were maintained on a Purina rodent chow diet and were allowed free access to feed and water except during the time they were removed from their cages for testing. In general, there were five animals per cage. Subsequently, at the time of the experiment each animal was placed in its own cage. All experiments were performed between 9:00 to 11:OO AM since it has been previously shown that maximal sensitivity to seizures occurs during this period (Davis and Webb, 1963) . All tested compounds were administered in a concentration that would keep the volume of the injection solution constant ( 1 ml/kg). Atropine and midazolam were dissolved in 0.9% NaCl immediately before injections. Drug doses were calculated as free base. Sources of the agents used were: atropine sulfate (Sigma Chemical Co., St. Louis, MO. 63178), diazepam commercial solution (m propylene glycol + 10% ethyl alcohol in water) and midazolam maleate (HofhnanLaRoche Inc., Nutley, N.J. 071 lo), and paraoxon (Sigma).
Study A. Gross behavioral changes and toxic symptoms induced by paraoxon were evaluated. Animals were injected sc with paraoxon in a dose range of 0.032-l .O mg/ kg. In these and subsequent experiments the rats were examined visually for toxic symptoms such as initial changes in activity (calmness, hyperexcitability, sleep, stupor), salivation, lacrimation, piloerection, eyeball protrusion (exophthalmos), and evidence of respiratory distress. Ataxia, sensory evoked hyperactivity, tremor, jerks, and generalized convulsions were recorded. The type of seizure was analyzed as tonic (tlexor and/or extensor) or clonic: mild, moderate (convulsions up to 5 set), and severe (convulsed repeatedly for more than 5 set). Recovery or death within 24 hr was evaluated. The mean convulsant dose 50% (CD50), the mean lethal dose 50% (LD50), and the 95% confidence limits were calculated by the method of Litchfield and Wilcoxon with an IMB PC computer (Tallarida and Murray, 198 1) .
Study B. Two series of experiments were undertaken. (1) Varying doses of atropine, diazepam, and midazolam alone or in combination were evaluated against 2X LDSO of paraoxon sc. Groups of eight rats at a minimum of five logarithmic doses of diazepam or midazolam (0.32-32.0 mg/kg) and atropine (1 .O-100.0 mg/kg) were used. Both compounds were given im since this is the most practical and rapid route of antidote administration. Pretreatment time (20 min) prior to paraoxon was based on data concerning absorption and peak plasma concentrations of midazolam following its im administration to humans. The control group of animals were pretreated with 0.9% NaCl (saline) or 40% propylene glycol + 10% ethyl alcohol in water.
(2). The LDSOs of sc paraoxon were evaluated in rats pretreated with atropine ( 10.0 m& im), midazolam (10.0 mg/kg, im), and/or diazepam (10.0 mg/k& im). The pretreatment time and route of drug injections were as above.
RESULTS

Study A
The sc administration of low doses (0.032-0.10 mg/kg) of paraoxon to rats induced slight gross behavioral changes like grooming, chewing, sniffing, and piloerection. A dose of 0.032 mg/kg caused (within 3-5 min) signs of cholinergic poisoning such as lacrimation, salivation, exophthalmos, fasciculations, tremor, and respiratory distress (bradypnea and dyspnea). Thirty percent of the animals developed moderate clonic seizures with a mild tonic component. Sixteen percent of the rats given a dose of 0.32 mg/kg died within 15-20 min. Adminstration of a larger dose ( 1 .O mg/kg) produced immediate toxic signs: tremor, jerks, and severe respiratory depression. All of these animals developed clonic seizures lasting 2-4 min until they died. Mortality in this group of rats was 100%.
The CD50 of paraoxon was determined to be 0.35 mg/kg with 95% confidence limits of 0.25-0.48. The LD50 calculated from the data was 0.38 mg/kg with 95% confidence limits of 0.27-0.52. (Fig. 1) . Therefore, this dose was selected for subsequent experiments. Larger doses of atropine (32.0-100.0 mg/kg) increased mortality slightly compared to the 10.0 mg/kg dose. Pretreatment with atropine did not prevent paraoxon-induced seizures. However, it decreased salivation, lacrimation, and respiratory distress.
2. Efict of midazolam alone. In these series of experiments, rats (eight per group) were injected with midazolam im in single doses (0.32, 1.0, 3.20, 10.0, and 32.0, mg/kg). Low doses of midazolam produced no obvious effect.
With larger doses (3.2-10.0 mg/kg) rapid absorption of midazolam from the im injection was apparent after 2-3 min (i.e., rats became calm). By 5 min, all of the animals showed skeletal muscle relaxation and some developed ataxia but none fell asleep. A dose of 32.0 mg/kg of midazolam produced an anesthesia like state.
3. Efect of midazolam pretreatment on paraoxon toxicity. The incidence of paraoxoninduced convulsions was signScantly reduced by prior adminstration of midazolam (Fig. 1) . Doses of 3.2-10.0 mg/kg produced 75-80% protection against seizures produced by 2X LD50 of paraoxon. However, midazolam alone only slightly prevented death (Fig. 2) . Pretreatment with both atropine (10.0 mg/kg) and midazolam (0.32-32.0 mg/kg) produced 100% protection against death. The combination of atropine ( 10.0 mg/kg) and midazolam (10.0 mg/kg) increased the LD50 of paraoxon to 4.12 (2.50-6.8 1 mg/kg, see Table 1 ). This pretreatment regime provided a protective ratio of 11.0.
4. E$ets of diazepam alone. In another series of experiments, the effect of diazepam in single doses im was tested. Low doses (0.32-3.2 mg/kg) produced no obvious effect. 15 min from injection to occurrence of the first signs was seen.
5. Efects of diazepam pretreatment on paraoxon toxicity. In diazepam-pretreated animals there was a dosedependent reduction in paraoxon-induced convulsions (Fig. 1 ). Small doses of diazepam (0.32-1 .O mg/kg) had no anticonvulsant activity. A dose of 32.0 mg/ kg reduced convulsions by 25%. Doses of diazepam from 10.0 to 32.0 mg/kg provided 7 1.8-100% protection against seizures. However, diazepam alone, even in a very large dose (32.0 mg/kg), did not prevent paraoxon-induced respiratory distress and death (Fig. 2) . Pretreatment with both atropine (10.0 mg/kg) and diazepam (10.0 mg/kg) provided 100% protection against death.
The combination of atropine ( 10.0 mg/kg) and diazepam (10.0 mg/kg) increased the LD50 of paraoxon to 2.72 (1.73428) mg/kg (Table 1) . This pretreatment regime provided a protective ratio of 7.16.
DISCUSSION
The manifestations of OP AChEI toxicity include hypersecretion, motor hyperactivity, fasciculations, convulsions, respiratory distress, and death. The cause of death has been attributed to both central and peripheral respiratory depression. Atropine showed a beneficial effect on impaired respiration caused by paraoxon and increased the LD50 by a factor of 3.1. The present studies confirm the finding that atropine is effective as an antidote to OP-induced respiratory failure (Johnson potentiation of the inhibitory effect of GABA and Wilcox, 1975; Lipp, 1976) . Atropine ap-(Cheng and Brunner, 198 1). Since midazolam pears to have at least three mechanisms of ac-is effective in suppressing paraoxon-induced tion in reducing respiratory depression: (1) it seizures, one can conclude that enhancement blocks the interaction between ACh and cho-of GABA mechanisms reduces paraoxon-inlinergic receptors in the central respiratory duced seizures. Perhaps paraoxon induces seicenter, (2) it reduces tracheobronchial secre-zures by a non-cholinergic mechanism related tion, and (3) it increases the heart rate which to inhibition of GABA. Of course, the other possibly enhances blood flow to the brainstem possibility remains that paraoxon-induced respiratory centers, thus reducing the anoxia convulsions are mediated through the release which results in activation of respiratory neu-of an excitatory transmitter such as glutamate, rons (Lipp, 1976) . However, atropine, when etc, in the brain which is affected by benzoinjected alone, does not antagonize seizures diazepines directly or indirectly. induced by paraoxon. We hypothesized that
In the present study, both benzodiazepines if the convulsions produced by paraoxon (and were very effective when combined with atroprobably other OP agents) were solely a result pine in reducing the incidence of paraoxonof activation of the cholinergic system, high induced seizures and dramatically reducing the doses of atropine would have abolished the lethality of 2X LDSO of paraoxon. However, convulsions, since an-opine pretreatment pre-midazolam was more potent on a milligram vents paraoxon-induced increases in brain per kilogram basis.
ACh amounts (Wecker et al., 1977) . Large
In atropine/midazolam-pretreated animals, doses (32.0-100.0 mg/kg) of atropine did not the LD50 of paraoxon was increased by a facantagonize paraoxon-induced seizures and tor of 11.0. Diazepam, when combined with were less effective in protecting against death atropine, increased the LD50 of paraoxon by than smaller doses (10.0 mg/kg) of atropine.
7.16. When given im to humans, midazolam Since atropine does not provide complete is better absorbed than is diazepam. Midazoprotection against OP poisoning, other forms lam, contrary to the present commercial diof therapy have been investigated. Benzodiazepam solution, is compatible when mixed azepines have been reported to provide both with other agents in the same syringe. Thus, protective and antidotal activity against poimidazolam would be preferred in treating soning by OP AChEI (Lipp, 1972 (Lipp, ,1973 (Lipp, ,1974  paraoxon poisoning, assuming that the tat data Rump et al., 1973; Johnson and Lowndes, are applicable to humans. 1974; Lundy et al., 1978; Jones et al., 1984) .
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azepam showed a similar effect, but it was less potent. REFERENCES Davies and Pole ( 1978) showed that iontophoretically administered midazolam an- anism of action of midazolam appears to be Exp. 9,263-267.
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